JP2015172090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015172090A5 JP2015172090A5 JP2015135830A JP2015135830A JP2015172090A5 JP 2015172090 A5 JP2015172090 A5 JP 2015172090A5 JP 2015135830 A JP2015135830 A JP 2015135830A JP 2015135830 A JP2015135830 A JP 2015135830A JP 2015172090 A5 JP2015172090 A5 JP 2015172090A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- antigen
- transplant
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96202207P | 2007-07-25 | 2007-07-25 | |
| US60/962,022 | 2007-07-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013110577A Division JP5926702B2 (ja) | 2007-07-25 | 2013-05-27 | Ｃｄ２００に対する抗体および免疫応答への使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016052050A Division JP2016117762A (ja) | 2007-07-25 | 2016-03-16 | Ｃｄ２００に対する抗体および免疫応答への使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015172090A JP2015172090A (ja) | 2015-10-01 |
| JP2015172090A5 true JP2015172090A5 (enExample) | 2016-05-12 |
Family
ID=40001380
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518230A Pending JP2010534243A (ja) | 2007-07-25 | 2008-07-25 | Ｃｄ２００に対する抗体および免疫応答への使用 |
| JP2013110577A Expired - Fee Related JP5926702B2 (ja) | 2007-07-25 | 2013-05-27 | Ｃｄ２００に対する抗体および免疫応答への使用 |
| JP2015135830A Pending JP2015172090A (ja) | 2007-07-25 | 2015-07-07 | Ｃｄ２００に対する抗体および免疫応答への使用 |
| JP2016052050A Pending JP2016117762A (ja) | 2007-07-25 | 2016-03-16 | Ｃｄ２００に対する抗体および免疫応答への使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518230A Pending JP2010534243A (ja) | 2007-07-25 | 2008-07-25 | Ｃｄ２００に対する抗体および免疫応答への使用 |
| JP2013110577A Expired - Fee Related JP5926702B2 (ja) | 2007-07-25 | 2013-05-27 | Ｃｄ２００に対する抗体および免疫応答への使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016052050A Pending JP2016117762A (ja) | 2007-07-25 | 2016-03-16 | Ｃｄ２００に対する抗体および免疫応答への使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | USRE46323E1 (enExample) |
| EP (1) | EP2178561A1 (enExample) |
| JP (4) | JP2010534243A (enExample) |
| KR (1) | KR20100041849A (enExample) |
| AU (1) | AU2008279619B2 (enExample) |
| BR (1) | BRPI0814644A2 (enExample) |
| CA (1) | CA2697159C (enExample) |
| MX (1) | MX2010000981A (enExample) |
| WO (1) | WO2009014745A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010534243A (ja) * | 2007-07-25 | 2010-11-04 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | Ｃｄ２００に対する抗体および免疫応答への使用 |
| BR112012020101A2 (pt) | 2010-02-11 | 2018-09-25 | Alexion Pharma Inc | método diagnósticos e terapêuticos usando anticorpos anti-cd200. |
| US9447187B2 (en) | 2011-02-03 | 2016-09-20 | Alexion Pharmaceuticals, Inc. | Use of an anti-CD200 antibody for prolonging the survival of allografts |
| WO2012167346A1 (en) | 2011-06-10 | 2012-12-13 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Anti-ricin antibodies and uses thereof |
| EP3626739A1 (en) | 2011-06-24 | 2020-03-25 | Stephen D. Gillies | Light chain immunoglobulin fusion proteins and methods of use thereof |
| US9737598B2 (en) | 2014-06-30 | 2017-08-22 | Regents Of The University Of Minnesota | CD200 inhibitors and methods of use thereof |
| JP2018504104A (ja) * | 2014-12-17 | 2018-02-15 | セレクティスＣｅｌｌｅｃｔｉｓ | 非Ｔ細胞伝達ドメインを発現する阻害性キメラ抗原受容体（ｉＣＡＲまたはＮ−ＣＡＲ） |
| EP3370763B1 (en) | 2015-11-03 | 2024-04-10 | Regents of the University of Minnesota | Cd200 inhibitors and methods of use thereof |
| JP7461741B2 (ja) | 2016-06-20 | 2024-04-04 | カイマブ・リミテッド | 抗ｐｄ－ｌ１およびｉｌ－２サイトカイン |
| WO2018102594A1 (en) * | 2016-12-01 | 2018-06-07 | Alexion Pharmaceuticals, Inc. | Methods of treating solid tumors with anti-cd200 antibodies |
| KR101968246B1 (ko) * | 2017-04-27 | 2019-04-11 | 서울대학교산학협력단 | 이종 각막 이식에서 항 cd20 단일클론항체 및 타클로리무스의 복합면역억제 방법 |
| US11761963B2 (en) | 2017-09-27 | 2023-09-19 | Alexion Pharmaceuticals, Inc. | Biomarker signature for predicting tumor response to anti-CD200 therapy |
| WO2019126133A1 (en) | 2017-12-20 | 2019-06-27 | Alexion Pharmaceuticals, Inc. | Liquid formulations of anti-cd200 antibodies |
| WO2019126536A1 (en) | 2017-12-20 | 2019-06-27 | Alexion Pharmaceuticals Inc. | Humanized anti-cd200 antibodies and uses thereof |
| WO2020150149A1 (en) | 2019-01-14 | 2020-07-23 | Regents Of The University Of Minnesota | Cd200ar ligands for cancer immunotherapy |
| EP4296280A1 (en) | 2022-06-21 | 2023-12-27 | F. Hoffmann-La Roche AG | Cd123 and cd200 as markers for the diagnosis and immune-eradication of leukemic stem cells (lscs) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7223729B2 (en) | 1997-11-07 | 2007-05-29 | Trillium Therapeutics Inc. | Methods of treating allergy by administering a CD200 protein |
| JP4584447B2 (ja) * | 1997-11-07 | 2010-11-24 | トリリアム・セラピューティクス・インコーポレイテッド | 免疫調節のための方法および組成物 |
| US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| CA2511513A1 (en) | 2002-12-27 | 2004-07-22 | Schering Corporation | Methods of inducing and maintaining immune tolerance |
| US8075884B2 (en) * | 2006-01-12 | 2011-12-13 | Alexion Pharmaceuticals, Inc. | Antibodies to OX-2/CD200 and uses thereof |
| US8986684B2 (en) | 2007-07-25 | 2015-03-24 | Alexion Pharmaceuticals, Inc. | Methods and compositions for treating autoimmune disease |
| JP2010534243A (ja) | 2007-07-25 | 2010-11-04 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | Ｃｄ２００に対する抗体および免疫応答への使用 |
-
2008
- 2008-07-25 JP JP2010518230A patent/JP2010534243A/ja active Pending
- 2008-07-25 CA CA2697159A patent/CA2697159C/en not_active Expired - Fee Related
- 2008-07-25 US US14/080,457 patent/USRE46323E1/en not_active Expired - Fee Related
- 2008-07-25 MX MX2010000981A patent/MX2010000981A/es active IP Right Grant
- 2008-07-25 AU AU2008279619A patent/AU2008279619B2/en not_active Ceased
- 2008-07-25 WO PCT/US2008/009037 patent/WO2009014745A1/en not_active Ceased
- 2008-07-25 KR KR1020107003921A patent/KR20100041849A/ko not_active Abandoned
- 2008-07-25 BR BRPI0814644-6A2A patent/BRPI0814644A2/pt not_active IP Right Cessation
- 2008-07-25 EP EP08794745A patent/EP2178561A1/en not_active Withdrawn
- 2008-07-25 US US12/670,379 patent/US8252285B2/en not_active Ceased
-
2012
- 2012-06-26 US US13/533,546 patent/US8637014B2/en active Active
-
2013
- 2013-05-27 JP JP2013110577A patent/JP5926702B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-07 JP JP2015135830A patent/JP2015172090A/ja active Pending
-
2016
- 2016-03-16 JP JP2016052050A patent/JP2016117762A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534243A5 (enExample) | ||
| JP2022501428A5 (enExample) | ||
| JP6242808B2 (ja) | 所望の特異性を有するモノクローナル自己抗体を提供する方法 | |
| JP5926702B2 (ja) | Ｃｄ２００に対する抗体および免疫応答への使用 | |
| CN111511765A (zh) | 抗半乳凝素-9抗体及其用途 | |
| Zaza et al. | Monoclonal antibody therapy and renal transplantation: focus on adverse effects | |
| WO2008137915A3 (en) | Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease | |
| AU2014220777B2 (en) | Anti-CD26 antibodies and uses thereof | |
| Mayer et al. | Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials | |
| JP2014505056A5 (enExample) | ||
| RU2017118985A (ru) | Антитела, их применение и способы применения | |
| ES2341341T3 (es) | Anticuerpos terapeuticos humanizados contra las isoformas cd45. | |
| Padiyar et al. | Induction antibody therapy in kidney transplantation | |
| JP2022163078A (ja) | 移植片対宿主病予防の方法 | |
| US12173081B2 (en) | CD19/CD38 multispecific antibodies | |
| JP2007529196A5 (enExample) | ||
| JP7825834B2 (ja) | 抗ｃ４ｄキメラ抗原受容体調節性ｔ細胞およびその使用 | |
| Bamoulid et al. | Advances in pharmacotherapy to treat kidney transplant rejection | |
| JP2024028850A (ja) | 抗ｐｄ－ｌ１抗体及びその製薬用途 | |
| Broeders et al. | Mycophenolate mofetil, together with cyclosporin A, prevents anti-OKT3 antibody response in kidney transplant recipients. | |
| JP2025066696A (ja) | 移植片対宿主病（ＧｖＨＤ）の防止又は処置のための抗ＣＣＲ７ ＭＡＢの使用 | |
| JP6881658B2 (ja) | Ｐｄ−１／ｃｄ３二重特異性タンパク質による血液がん治療 | |
| Sulemanjee et al. | The first year post–heart transplantation: Use of immunosuppressive drugs and early complications | |
| US20210395343A1 (en) | Ivig composition and method of treatment of antibody deficient patients | |
| Atanasov et al. | Induction and Maintenance Immunosuppression in Intestinal Transplantation |